Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog

Europace

Volumn 14, Issue 3, 2012, Pages 431-436

  Dunnink, Albert ^a   Van Opstal, Jurren M ^b   Oosterhoff, Peter ^a,c   Winckels, Stephan K G ^a   Beekman, Jet D M ^a   Van Der Nagel, Roel ^a   Cora Verduyn, S ^b   Vos, Marc A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

Shortlongshort sequence; Timing of drug administration; Ventricular activation; Ventricular remodelling

Indexed keywords

DOFETILIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; COMPLETE HEART BLOCK; DISEASE PREDISPOSITION; DOG; FEMALE; HEART ARRHYTHMIA; HEART PACING; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM; MALE; NONHUMAN; PRIORITY JOURNAL; TORSADE DES POINTES;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; DOGS; FEMALE; MALE; PHENETHYLAMINES; SULFONAMIDES; TORSADES DE POINTES; VENTRICULAR REMODELING;

EID: 84857847723     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur311     Document Type: Article

References (28)

1. Belardinelli L, Antzelevitch C, Vos MA. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci 2003;24:619-25. (Pubitemid 37494783)
2. Brendorp B, Pedersen O, Torp-Pedersen C, Sahebzadah N, Kober L. A benefit-risk assessment of class III antiarrhythmic agents. Drug Saf 2002;25: 847-65. (Pubitemid 35178643)
3. Roden DM. Taking the 'idio' out of 'idiosyncratic': Predicting torsades de pointes. Pacing Clin Electrophysiol 1998;21:1029-34.
4. Thomsen MB, Volders PG, Stengl M, Spatjens RL, Beekman JD, Bischoff U et al. Electrophysiological safety of sertindole in dogs with normal and remodeled hearts. J Pharmacol Exp Ther 2003;307:776-84. (Pubitemid 37310695)
5. Jonsson MK, Vos MA, Duker G, Demolombe S, van Veen TA. Gender disparity in cardiac electrophysiology: Implications for cardiac safety pharmacology. Pharmacol Ther 2010;127:9-18.
6. Vos MA, Verduyn SC, Gorgels AP, Lipcsei GC, Wellens HJ. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995;91: 864-72.
7. Locati EH, Maison-Blanche P, Dejode P, Cauchemez B, Coumel P. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings. J Am Coll Cardiol 1995; 25:1564-75.
8. Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson JW, Sheldon T. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: A possible mechanism of proarrhythmia?. J Am Coll Cardiol 2007;50: 614-22. (Pubitemid 47199010)
9. Viskin S, Fish R, Zeltser D, Belhassen B, Heller K, Brosh D et al. Arrhythmias in the congenital long QT syndrome: How often is torsade de pointes pause dependent?. Heart 2000;3:661-6. (Pubitemid 30345967)
10. Thomsen MB, Volders PG, Beekman JD, Matz J, Vos MA. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Am Coll Cardiol 2006;48:1268-76. (Pubitemid 44345129)
11. Dunnink A, Sharif S, Oosterhoff P, Winckels S, Montagne D, Beekman J et al. Anesthesia and arrhythmogenesis in the chronic atrioventricular block dog model. J Cardiovasc Pharmacol 2010;55:601-8.
12. Choy AM, Darbar D, Dell'Orto S, Roden DM. Exaggerated QT prolongation after cardioversion of atrial fibrillation. J Am Coll Cardiol 1999;34:396-401.
13. Darbar D, Kimbrough J, Jawaid A, McCray R, Ritchie MD, Roden DM. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome. J Am Coll Cardiol 2008;51:836-42. (Pubitemid 351253747)
14. Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk LV, Harry JD et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 1998;79: 568-75. (Pubitemid 28289279)
15. Oros A, Beekman JD, Vos MA. The canine model with chronic, complete atrio-ventricular block. Pharmacol Ther 2008;119:168-78.
16. Thomsen MB, Oros A, Schoenmakers M, van Opstal JM, Maas JN, Beekman JD et al. Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation. Cardiovasc Res 2007;73:521-30. (Pubitemid 46073954)
17. Timmermans C, Rodriguez LM, Van Suylen RJ, Leunissen J, Vos M, Ayers GM et al. Catheter-based cryoablation produces permanent bidirectional cavotricuspid isthmus conduction block in dogs. J Interv Card Electrophysiol 2002;7:149-55. (Pubitemid 35462311)
18. Thomsen MB, Verduyn SC, Stengl M, Beekman JD, de Pater G, van Opstal J et al. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation 2004;110:2453-9. (Pubitemid 39407353)
19. de Groot SH, Schoenmakers M, Molenschot MM, Leunissen JD, Wellens HJ, Vos MA. Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart to delayed afterdepolarization-dependent ventricular arrhythmias. Circulation 2000;102:2145-51.
20. Verduyn SC, Ramakers C, Snoep G, Leunissen JD, Wellens HJ, Vos MA. Time course of structural adaptations in chronic AV block dogs: Evidence for differential ventricular remodeling. Am J Physiol Heart Circ Physiol 2001;280:H2882-90.
21. Donker DW, Volders PG, Arts T, Bekkers BC, Hofstra L, Spatjens RL et al. Enddiastolic myofiber stress and ejection strain increase with ventricular volume overload-serial in-vivo analyses in dogs with complete atrioventricular block. Basic Res Cardiol 2005;100:372-82. (Pubitemid 40974088)
22. Peschar M, Vernooy K, Vanagt WY, Reneman RS, Vos MA, Prinzen FW. Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles. Cardiovasc Res 2003;58:510-7. (Pubitemid 36694436)
23. Oosterhoff P, Thomsen MB, Maas JN, Atteveld NJ, Beekman JD, van Rijen HV et al. High-Rate pacing reduces variability of repolarization and prevents repolarization-dependent arrhythmias in dogs with chronic AV block. J Cardiovasc Electrophysiol 2010;21:1384-91.
24. Boriani G, Diemberger I, Biffi M, Martignani C, Branzi A. Pharmacological cardioversion of atrial fibrillation: Current management and treatment options. Drugs 2004;64:2741-62. (Pubitemid 40011860)
25. Mazur A, Anderson ME, Bonney S, Roden DM. Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: A placebocontrolled, implantable cardioverter-defibrillator-based evaluation. J Am Coll Cardiol 2001;37:1100-5. (Pubitemid 32217613)
26. van Opstal JM, Schoenmakers M, Verduyn SC, de Groot SH, Leunissen JD, van Der Hulst FF et al. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 2001;104:2722-7. (Pubitemid 33108141)
27. Verduyn SC, Vos MA, van der Zande J, Kulcsar A, Wellens HJ. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol 1997;30:1575-84. (Pubitemid 27486478)
28. Winckels SK, Thomsen MB, Oosterhoff P, Oros A, Beekman JD, Attevelt NJ et al. High-septal pacing reduces ventricular electrical remodeling and proarrhythmia in chronic atrioventricular block dogs. J Am Coll Cardiol 2007;50:906-13 (Pubitemid 47277499)